787 related articles for article (PubMed ID: 23545506)
21. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
22. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
[TBL] [Abstract][Full Text] [Related]
23. Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy.
Midtvedt K; Bjorang O; Letting AS
Clin Transplant; 2007; 21(4):571-3. PubMed ID: 17645722
[TBL] [Abstract][Full Text] [Related]
24. BK virus viremia in a well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression.
Helanterä I; Salmela K; Kyllönen L; Räisänen-Sokolowski A; Auvinen E; Mannonen L; Koskinen P; Lautenschlager I
Clin Transplant; 2012; 26(6):E596-601. PubMed ID: 23083418
[TBL] [Abstract][Full Text] [Related]
25. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
26. Biopsy-Proven BK Virus-Associated Nephropathy: Clinico-Pathologic Correlations.
Jahdali S; Al Oudah N; Alsaad KO; Kfoury H; Qurashi S; Al Sayyari A
Exp Clin Transplant; 2017 Jun; 15(3):289-294. PubMed ID: 28137206
[TBL] [Abstract][Full Text] [Related]
27. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples.
Babel N; Fendt J; Karaivanov S; Bold G; Arnold S; Sefrin A; Lieske E; Hoffzimmer M; Dziubianau M; Bethke N; Meisel C; Grütz G; Reinke P
Transplantation; 2009 Jul; 88(1):89-95. PubMed ID: 19584686
[TBL] [Abstract][Full Text] [Related]
28. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
[TBL] [Abstract][Full Text] [Related]
29. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Hässig A; Roos M; Etter A; Bossart W; Müller N; Schiesser M; Wüthrich RP; Fehr T
Transpl Infect Dis; 2014 Feb; 16(1):44-54. PubMed ID: 24134704
[TBL] [Abstract][Full Text] [Related]
30. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
Gabardi S; Townsend K; Martin ST; Chandraker A
Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
[TBL] [Abstract][Full Text] [Related]
32. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
Al-Raisi F; Mohsin N; Kamble P
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
[TBL] [Abstract][Full Text] [Related]
33. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
34. Renal Function Impairment in Kidney Transplantation: Importance of Early BK Virus Detection.
Manzano Sánchez D; Jimeno García L; Manzano Sánchez D; López Jiménez I; Saura Luján IM; González Soriano MJ; Llorente Viñas S; Gil Muñoz M; Carbajo Mateo T
Transplant Proc; 2019 Mar; 51(2):350-352. PubMed ID: 30879539
[TBL] [Abstract][Full Text] [Related]
35. BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report.
Nampoory MR; Johny KV; Pacsa A; Nair PM; Said T; Halim MA; Francis I; Samhan M; Mousawi M; Dalawi A; Szucs G; Al-Nakib W
Transplant Proc; 2005 Sep; 37(7):3048-50. PubMed ID: 16213300
[TBL] [Abstract][Full Text] [Related]
36. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Oct; 96(7):e51. PubMed ID: 24100844
[No Abstract] [Full Text] [Related]
37. Polyomavirus (BK) in pediatric renal transplants: evaluation of viremic patients with and without BK associated nephritis.
Hymes LC; Warshaw BL
Pediatr Transplant; 2006 Dec; 10(8):920-2. PubMed ID: 17096758
[TBL] [Abstract][Full Text] [Related]
38. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
[TBL] [Abstract][Full Text] [Related]
39. Clinical courses of renal transplant recipients with high BK viremia.
Kim H; Yang WS; Han DJ; Park SK
Transplant Proc; 2013 Oct; 45(8):2975-9. PubMed ID: 24157016
[TBL] [Abstract][Full Text] [Related]
40. Association of DNA amplification with progress of BK polyomavirus infection and nephropathy in renal transplant recipients.
Hasegawa M; Ito T; Saigo K; Akutsu N; Maruyama M; Otsuki K; Aoyama H; Matsumoto I; Asano T; Kitamura H; Kenmochi T
Transplant Proc; 2014; 46(2):556-9. PubMed ID: 24656011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
